Your institution may have access to this item. Find your institution then sign in to continue.
Title
18F-FDG PET as a surrogate biomarker in non-small cell lung cancer treated with erlotinib: newly identified lesions are more informative than standardized uptake value.
Authors
Bengtsson, Thomas; Hicks, Rodney J; Peterson, Amy; Port, Ruediger E
Abstract
This study assesses the predictive value of (18)F-FDG PET for overall survival in lung cancer patients treated with a targeted drug.
Publication
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Vol 53, Issue 4, p530